FDA inspection
Cambrex High Point, Inc.: FDA inspection ending Dec 17, 2014
FDA inspection 909521 · No Action Indicated (NAI) · High Point, NC
Key facts
| Inspection ID | 909521 |
|---|---|
| Firm | Cambrex High Point, Inc. |
| FEI number | 3003568775 |
| Address | 4180 Mendenhall Oaks Pkwy |
| City | High Point |
| State | NC |
| ZIP | 27265 |
| Country | United States |
| Fiscal year | 2015 |
| Inspection end date | Dec 17, 2014 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data